Barinthus Biotherapeutics BRNS
NASDAQ BRNS
$0.62 +0.01 (+1.11%)
As of: Aug 21, 2026 · 11:43 AM EDT

Barinthus Biotherapeutics (BRNS) Net Margin (QoQ) (2020 - 2023)

Barinthus Biotherapeutics (BRNS) Net Margin (QoQ) (2020 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.51 Bn 78.51 Bn 3.93 Bn
3 Argenx Se 65.74 Bn 60.56 Bn 1.37 Bn
4 Moderna 59.39 Bn 54.26 Bn 52.00 Mn
5 BeOne Medicines 42.24 Bn 37.15 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.78 Bn 28.47 Bn 992.69 Mn
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn
9 Royalty Pharma 27.22 Bn 26.39 Bn -
10 Barinthus Biotherapeutics 25.29 Mn 25.29 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 -323,913.00
Mar 31, 2023 -356,605.00
Dec 31, 2022 -46,110.00
Sep 30, 2022 4,140.00
Jun 30, 2022 7,481.00
Mar 31, 2022 -168.19 Mn
Dec 31, 2021 171.90 Mn
Sep 30, 2021 1.11 Mn
Jun 30, 2021 -4.41 Mn
Mar 31, 2021 -43,791.00
Dec 31, 2020 -356,045.00
Sep 30, 2020 80,376.00
Jun 30, 2020 -20,742.00